Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction

Journal of Neurochemistry

Volumn 108, Issue 3, 2009, Pages 787-795

  Godavarthi, Swetha K ^a   Narender, Doronala ^a   Mishra, Amit ^a   Goswami, Anand ^a   Rao, Sudheendra N R ^a   Nukina, Nobuyuki ^b   Jana, Nihar Ranjan ^a  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Chemokine; Huntington's disease; Inflammation; Monocyte chemoattractant protein 1; Murine chemokine; Proteasome

Indexed keywords

GAMMA INTERFERON; HUNTINGTIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEASOME; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; GENETIC TRANSFECTION; HUNTINGTON CHOREA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES, CC; GENES, REPORTER; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NERVE TISSUE PROTEINS; NEURONS; NF-KAPPA B; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; VIRAL PROTEINS;

MURINAE; MUS MUSCULUS;

EID: 58149328522     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05823.x     Document Type: Article

References (45)

1. Apostol B. L., Illes K., Pallos J. et al. (2006) Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity. Hum. Mol. Genet. 15, 273 285.
2. Bae B., Xu H., Igarashi S. et al. (2005) p53 Mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47, 29 41.
3. Baeuerle P. A. Henkel T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141 179.
4. Bates G. P. (2005) History of genetic disease: the molecular genetics of Huntington disease - a history. Nat. Rev. Genet. 6, 766 773.
5. Bence N. F., Sampat R. M. Kopito R. R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552 1555.
6. Bennett E. J., Bence N. F., Jayakumar R. Kopito R. R. (2005) Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell. 17, 351 365.
7. Bennett E. J., Shaler T. A., Woodman B., Ryu K. Y., Zaitseva T. S., Becker C. H., Bates G. P., Schulman H. Kopito R. R. (2007) Global changes to the ubiquitin system in Huntington's disease. Nature 448, 704 708.
8. Bett J. S., Goellner G. M., Woodman B., Pratt G., Rechsteiner M. Bates G. P. (2006) Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target. Hum. Mol. Genet. 15, 33 44.
9. Biber K., Zuurman M. W., Dijkstra I. M. Boddeke H. W. (2002) Chemokines in the brain: neuroimmunology and beyond. Curr. Opin. Pharmacol. 2, 63 68.
10. Cartier L., Hartley O., Dubois-Dauphin M. Krause K. H. (2005) Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Rev. 48, 16 42.
11. Cha J. H. (2000) Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 23, 387 392.
12. Chou S. Y., Weng J. Y., Lai H. L., Liao F., Sun S. H., Tu P. H., Dickson D. W. Chern Y. (2008) Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes. J. Neurosci. 28, 3277 3290.
13. Di Prospero N. A. Fischbeck K. H. (2005) Therapeutics development for triplet repeat expansion diseases. Nat. Rev. Genet. 6, 756 765.
14. Diaz-Hernandez M., Valera A. G., Moran M. A., Gomez-Ramos P., Alvarez-Castelao B., Castano J. G., Hernandez F. Lucas J. J. (2006) Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain. J. Neurochem. 98, 1585 1596.
15. Evert B. O., Vogt I. R., Kindermann C., Ozimek L., de Vos R. A., Brunt E. R., Schmitt I., Klockgether T. Wullner U. (2001) Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J. Neurosci. 21, 5389 5396.
16. Flugel A., Hager G., Horvat A., Spitzer C., Singer G. M., Graeber M. B., Kreutzberg G. W. Schwaiger F. W. (2001) Neuronal MCP-1 expression in response to remote nerve injury. J. Cereb. Blood Flow Metab. 21, 69 76.
17. Gatchel J. R. Zoghbi H. Y. (2005) Diseases of unstable repeat expansion: mechanisms and common principles. Nat. Rev. Genet. 6, 743 755.
18. Goswami A., Dikshit P., Mishra A., Nukina N. Jana N. R. (2006) Expression of expanded polyglutamine proteins suppresses the activation of transcription factor NF-kB. J. Biol. Chem. 281, 37017 37024.
19. Heneka M. T. O'Banion M. K. (2007) Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184, 69 91.
20. Hensley K., Mhatre M., Mou S., Pye Q. N., Stewart C., West M. Williamson K. S. (2006) On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid. Redox Signal. 8, 2075 2087.
21. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72, 971 983.
22. Jana N. R. Nukina N. (2003) Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway. J. Chem. Neuroanat. 26, 95 101.
23. Jana N. R., Tanaka M., Wang G. Nukina N. (2000) Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet. 9, 2009 2018.
24. Jana N. R., Zemskov E. A., Wang G. Nukina N. (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet. 10, 1049 1059.
25. Ma L., Morton A. J. Nicholson L. F. (2003) Microglia density decreases with age in a mouse model of Huntington's disease. Glia 43, 274 280.
26. Merienne K., Friedman J., Akimoto M., Abou-Sleymane G., Weber C., Swaroop A. Trottier Y. (2007) Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy. Neurobiol. Dis. 25, 571 581.
27. Mines M., Ding Y. Fan G. H. (2007) The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies. Curr. Med. Chem. 14, 2456 2470.
28. Morfini G., Pigino G., Szebenyi G., You Y., Pollema S. Brady S. T. (2006) JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 9, 907 916.
29. Myers R. H., Vonsattel J. P., Paskevich P. A., Kiely D. K., Stevens T. J., Cupples L. A., Richardson E. P. Jr. Bird E. D. (1991) Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J. Neuropathol. Exp. Neurol. 50, 729 742.
30. Nakayama K., Furusu A., Xu Q., Konta T. Kitamura M. (2001) Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway. J. Immunol. 167, 1145 1150.
31. Nucifora F. C., Sasaki M., Peters M. F. et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423 2428.
32. Ortega Z., Diaz-Hernandez M. Lucas J. J. (2007) Is the ubiquitin-proteasome system impaired in Huntington's disease? Cell. Mol. Life Sci. 64, 2245 2257.
33. Rubinsztein D. C. (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443, 780 786.
34. Sapp E., Kegel K. B., Aronin N., Hashikawa T., Uchiyama Y., Tohyama K., Bhide P. G., Vonsattel J. P. DiFiglia M. (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 60, 161 172.
35. Shimohata T., Nakajima T., Yamada M. et al. (2000) Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat. Genet. 26, 29 36.
36. Simmons D. A., Casale M., Alcon B., Pham N., Narayan N. Lynch G. (2007) Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 55, 1074 1084.
37. Sotrel A., Paskevich P. A., Kiely D. K., Bird E. D., Williams R. S. Myers R. H. (1991) Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 41, 1117 1123.
38. Sugars K. L. Rubinsztein D. C. (2003) Transcriptional abnormalities in Huntington's disease. Trends Genet. 19, 133 238.
39. Tsirigotis M., Baldwin R. M., Tang M. Y., Lorimer I. A. Gray D. A. (2008) Activation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity. PLoS ONE 3, e2130.
40. Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G. P. Davies S. W. (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl Acad. Sci. USA 97, 8093 8097.
41. Ueda A., Okuda K., Ohno S., Shirai A., Igarashi T., Matsunaga K., Fukushima J., Kawamoto S., Ishigatsubo Y. Okubo T. (1994) NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153, 2052 2063.
42. Venkatraman P., Wetzel R., Tanaka M., Nukina N. Goldberg A. L. (2004) Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol. Cell. 14, 95 104.
43. Wang Q., Tang X. N. Yenari M. A. (2007) The inflammatory response in stroke. J. Neuroimmunol. 184, 53 68.
44. Wang J., Wang C. E., Orr A., Tydlacka S., Li S. H. Li X. J. (2008) Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J. Cell Biol. 180, 1177 1189.
45. Zoghbi H. Y. Orr H. T. (2000) Glutamine repeats and neurodegeneration. Ann. Rev. Neurosci. 23, 217 247.